A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)

A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)

Dexamethasone implant, 0,7 mg (Ozurdex, Allergan, Inc., Irvine, CA, USA), is drug mostly used in the treatment of the diabetic macular edema and edema related to retinal vein occlusion. By reporting this case we aimed to report a new side effect of 0.7 mg intravitreal dexamethasone implant that has...

Full description

Saved in:
Bibliographic Details
Main Authors: Erdem Eris, Gurkan Erdogan, Irfan Perente, Gokhan Demir, Burcin Kepez Yildiz, Ebru Demet Aygit
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Case Reports in Ophthalmological Medicine
Online Access:http://dx.doi.org/10.1155/2017/6369085
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items